After asthma: redefining airways diseases

Title: After asthma: redefining airways diseases
Creator: Pavord, Ian D.; Beasley, Richard; Frey, Urs; Gibson, Peter; Heaney, Liam G.; Holt, Patrick G.; Humbert, Marc; Lloyd, Clare M.; Marks, Guy; Martinez, Fernando D.; Sly, Peter D.; von Mutius, Erika; Agusti, Alvar; Wenzel, S; Zar, HJ; Bush, A; Anderson, Gary P.; Bel, Elisabeth; Brusselle, Guy; Cullinan, Paul; Custovic, Adnan; Ducharme, Francine M.; Fahy, John V.
Relation: The Lancet Vol. 391, Issue 10118, p. 350-400
Publisher Link: http://dx.doi.org/10.1016/S0140-6736(17)30879-6
Publisher: Elsevier
Resource Type: journal article
Date: 2018
Description: Asthma is responsible for considerable global morbidity and health-care costs. Substantial progress was made against key outcomes such as hospital admissions with asthma and mortality in the 1990s and early 2000s, but little improvement has been observed in the past 10 years, despite escalating treatment costs. New assessment techniques are not being adopted and new drug discovery has progressed more slowly than in other specialties.
Subject: asthma; breathing disorder; morbidity; mortality rate; SDG 3; Sustainable Development Goals
Identifier: http://hdl.handle.net/1959.13/1447023
Identifier: uon:43034
Identifier: ISSN:0140-6736
Language: eng
Reviewed